Indication

Hypercholesterolemia

Hypercholesterolemia is a metabolic lipid disorder characterized by abnormally elevated concentrations of circulating total cholesterol and low-density lipoprotein cholesterol (LDL-C) in the bloodstream. Read more about Hypercholesterolemia

373 drugs 141 manufacturers

Advertisement

Drugs that treat it

Common Hypercholesterolemia therapies.

Showing 298–306 of 373 drugs

PRAVASTATIN SODIUM

ANTIHYPERLIPIDEMICS HMGCO-A REDUCTASE INHIBITORS (STATINS)·HYPERCHOLESTEROLEMIA·+11
CIPLA USA, INC.

ROSUVASTATIN CALCIUM

ANTIHYPERLIPIDEMICS HMGCO-A REDUCTASE INHIBITORS (STATINS)·HYPERCHOLESTEROLEMIA·+11
WESTMINSTER PHA

PRAVASTATIN SODIUM

ANTIHYPERLIPIDEMICS HMGCO-A REDUCTASE INHIBITORS (STATINS)·HYPERCHOLESTEROLEMIA·+11
BIOCON PHARMA I

ATORVASTATIN CALCIUM

ANTIHYPERLIPIDEMICS HMGCO-A REDUCTASE INHIBITORS (STATINS)·HYPERCHOLESTEROLEMIA·+11
REMEDYREPACK, I

ATORVASTATIN CALCIUM

ANTIHYPERLIPIDEMICS HMGCO-A REDUCTASE INHIBITORS (STATINS)·HYPERCHOLESTEROLEMIA·+11
ZYDUS PHARMACEU

ATORVASTATIN CALCIUM

ANTIHYPERLIPIDEMICS HMGCO-A REDUCTASE INHIBITORS (STATINS)·HYPERCHOLESTEROLEMIA·+11
LIFESTAR PHARMA

ATORVASTATIN CALCIUM

ANTIHYPERLIPIDEMICS HMGCO-A REDUCTASE INHIBITORS (STATINS)·HYPERCHOLESTEROLEMIA·+11
DENTON PHARMA I

PRAVASTATIN SODIUM

ANTIHYPERLIPIDEMICS HMGCO-A REDUCTASE INHIBITORS (STATINS)·HYPERCHOLESTEROLEMIA·+11
DENTON PHARMA I
Filter & compare in the drug finder →Opens the drug finder with Hypercholesterolemia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Hypercholesterolemia.

Hypercholesterolemia is a metabolic lipid disorder characterized by abnormally elevated concentrations of circulating total cholesterol and low-density lipoprotein cholesterol (LDL-C) in the bloodstream.

Primarily impacting the cardiovascular and vascular systems across pediatric and adult populations, it can arise from primary polygenic or monogenic defects, such as low-density lipoprotein receptor mutations, or secondary causes including metabolic disease, diet, and medications.

Pathophysiologically, the sustained excess of atherogenic lipoprotein particles promotes their infiltration, oxidation, and accumulation within arterial walls, driving systemic atherosclerosis and markedly increasing the risk of coronary artery disease, myocardial infarction, and ischemic stroke.

Personalize your experience

Follow Hypercholesterolemia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it